The NAFLD/NASH medications' page includes specific information about each of the experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads.
By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.